Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2022-03-30 Capital/Financing Update
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors at their meeting held ....
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting. It announces the allotment of equity shares arising from the conversion of fully convertible warrants to entities in the promoter group. The document references compliance with SEBI regulations related to capital issuance and disclosure. It details the number of shares allotted, the increase in total equity shares, and lock-in provisions. There is no financial statement or detailed financial analysis present, nor is it a report or presentation. The content is an update on a capital structure change (share allotment) approved by the board. The document length is about 4500 characters, which is relatively short and focused on a specific corporate action. Therefore, the most appropriate classification is a Capital/Financing Update (CAP).
2022-03-30 English
Loss of share certificate
Regulatory Filings
2022-03-24 English
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2022-03-22 English
Extra Ordinary Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as "Proceedings of the Extra-Ordinary General Meeting held on Saturday, 5th March, 2022" and details the conduct of the meeting, including the chairman, quorum, agenda items, voting procedures, and appointment of a scrutinizer. It explicitly states it is the proceedings of the EGM and not the minutes. There is no financial data, no audit information, no earnings or management discussion, nor is it a notice or announcement of a report publication. The document is a formal record of the meeting proceedings, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder meeting proceedings and voting processes. The document is over 6000 characters, so it is not a brief announcement but a substantive meeting proceeding report. Therefore, the best classification is DVA.
2022-03-06 English
Extra Ordinary Meeting
Regulatory Filings
2022-03-06 English
Extra Ordinary Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as "Proceedings of the Extra-Ordinary General Meeting held on Saturday, 5th March, 2022" and contains a detailed summary of the meeting's conduct, including the chairman's address, quorum confirmation, agenda items, voting procedures, and appointment of the scrutinizer. It explicitly states that it is the gist of the proceedings of the EGM and not the minutes. There is no financial data, no audit information, no earnings or interim report content, nor is it a notice or announcement of a report publication. The document is a formal record of the meeting proceedings, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder meeting proceedings and voting processes. Although the actual voting results are to be separately intimated, this document serves as the official proceedings summary of the EGM, which is typically classified under DVA. The document length (6148 characters) supports it being a substantive meeting proceedings document rather than a brief announcement or notice. Therefore, the best fitting classification is DVA with high confidence.
2022-03-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.